Consensus statement for the continuation of Parkinson’s medicines in hospitals

This consensus statement outlines key medicine management issues for people with Parkinson's in hospitals, emphasising timely medication and effective management strategies.

Last reviewed
Topic
  • Care strategies
  • Inpatient care and medicines management
  • Service improvement
Resource type
  • Publications
Profession
  • Dietitian
  • Doctor (Geriatrician)
  • Doctor (Neurologist)
  • Nurse (other)
  • Nurse (Parkinson's nurse)
  • Occupational therapist
  • Pharmacist
  • Physiotherapist
  • Psychiatrist
  • Psychologist
  • Speech and language therapist
Stage
  • Complex
  • End of life
  • Maintenance

Who are these guidelines for?

This consensus statement provides essential guidance for health professionals managing people with Parkinson's in hospital settings. Developed by the Parkinson's UK Excellence Network, it addresses critical issues surrounding medication management, highlighting the severe consequences of delayed or disrupted Parkinson's medication.

Templates for local adoption

The document offers practical tools and templates for policy makers to develop local guidelines for prescribing and administering Parkinson's medicines for inpatients. 

It includes:

  • admissions checklists

  • clinical assessment guidance

  • information on managing non-oral medications

  • surgical considerations.

By supporting timely and appropriate medication, these resources aim to improve patient outcomes, reduce hospital stays, and alleviate stress for people with Parkinson's and their families. Further resources for staff training and patient support are also provided to ensure comprehensive care.

This version of the Consensus statement for the continuation of Parkinson’s medicines in hospitals, updates a previous version of the Medicines optimisation consensus statement which was first published by Parkinson’s UK in 2017. Its development was led by Dr Paul Worth, Consultant Neurologist at Cambridge University Hospitals NHS Foundation Trust and a steering group of key professionals and Anne Ferrett, a member of the Parkinson's community.